An interventional study of Kinesio Taping in Delayed-Onset Muscle Soreness, sponsored by Firat University. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-25.
Sponsored by Firat University · Not applicable, Interventional, and Supportive care
This study evaluates the effects of kinesio taping applied to the quadriceps femoris on delayed-onset muscle soreness, lower-extremity range of motion, and explosive jump performance following a fatiguing exercise protocol in healthy sedentary males.
Participants undergo a fatiguing sit-to-stand exercise protocol to induce exercise-induced muscle damage. Using a controlled crossover design with repeated measurements, participants complete both a kinesio taping (KT) condition and a non-taping (N-KT) control condition, separated by a 96-hour washout period. Measurements including subjective muscle soreness, active range of motion of the hip, knee, and ankle joints, thigh circumference, and squat jump performance are evaluated at baseline, 24, 48, and 72 hours post-exercise.
256 studies on the registry are indexed under Myalgia; 46 are open to participants now.
This study's enrollment of 15 is below the median of 44 across 216 interventional studies indexed under Myalgia.
Browse Myalgia studies →Firat University is the lead sponsor of 117 studies on the registry; 46 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Application of Y-shaped kinesio tape to the quadriceps femoris muscle with 25%-50% tension immediately after the fatigue protocol.
Device: Kinesio Taping
Participants complete the fatiguing protocol without any taping application during the recovery period.
Therapeutic taping applied to the anterior thigh to evaluate recovery kinetics.
Delayed-Onset Muscle Soreness (DOMS)
Assessed using the Visual Analog Scale (VAS), where scores range from 0 (no pain) to 10 (very severe pain).
Time frame: Baseline (0 hour), 24 hours, 48 hours, and 72 hours post-exercise
Squat Jump Performance
Assessed using a digital contact mat system to measure explosive jump height in centimeters.
Time frame: Baseline (0 hour), 24 hours, 48 hours, and 72 hours post-exercise
Joint Range of Motion (ROM)
Active range of motion of hip, knee, and ankle joints measured in degrees using a universal goniometer.
Time frame: Baseline (0 hour), 24 hours, 48 hours, and 72 hours post-exercise
Thigh Circumference
Measured in centimeters at the marked anatomical landmark (15 cm proximal to the superior border of the patella) to track tissue edema.
Time frame: Baseline (0 hour), 24 hours, 48 hours, and 72 hours post-exercise
Plan to share: Yes — The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request.
Supporting information: Study protocol
Time frame: Following publication of the study results.
Access criteria: Upon reasonable request directed to the corresponding author via email.
No publications or documents are linked to this record.
Ran from Mar 2025 to primary completion in May 2025, 1 month.
Of 101 non-industry interventional studies with no phase under Myalgia, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 16. This study's 1 month is below that.
Counting every sponsor, half of 111 studies reached it within 8 months; a quarter within 3 and three quarters within 16.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.